1. Home
  2. SMCI vs TEVA Comparison

SMCI vs TEVA Comparison

Compare SMCI & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMCI
  • TEVA
  • Stock Information
  • Founded
  • SMCI 1993
  • TEVA 1901
  • Country
  • SMCI United States
  • TEVA Israel
  • Employees
  • SMCI N/A
  • TEVA N/A
  • Industry
  • SMCI Computer Manufacturing
  • TEVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMCI Technology
  • TEVA Health Care
  • Exchange
  • SMCI Nasdaq
  • TEVA Nasdaq
  • Market Cap
  • SMCI 18.7B
  • TEVA 18.4B
  • IPO Year
  • SMCI 2007
  • TEVA N/A
  • Fundamental
  • Price
  • SMCI $32.11
  • TEVA $18.08
  • Analyst Decision
  • SMCI Buy
  • TEVA Strong Buy
  • Analyst Count
  • SMCI 17
  • TEVA 6
  • Target Price
  • SMCI $52.15
  • TEVA $24.33
  • AVG Volume (30 Days)
  • SMCI 43.5M
  • TEVA 12.8M
  • Earning Date
  • SMCI 05-06-2025
  • TEVA 05-07-2025
  • Dividend Yield
  • SMCI N/A
  • TEVA N/A
  • EPS Growth
  • SMCI 2.04
  • TEVA N/A
  • EPS
  • SMCI 1.84
  • TEVA N/A
  • Revenue
  • SMCI $21,569,720,000.00
  • TEVA $16,616,000,000.00
  • Revenue This Year
  • SMCI $66.12
  • TEVA $6.30
  • Revenue Next Year
  • SMCI $34.25
  • TEVA N/A
  • P/E Ratio
  • SMCI $17.49
  • TEVA N/A
  • Revenue Growth
  • SMCI 82.49
  • TEVA 3.82
  • 52 Week Low
  • SMCI $17.25
  • TEVA $12.47
  • 52 Week High
  • SMCI $101.40
  • TEVA $22.80
  • Technical
  • Relative Strength Index (RSI)
  • SMCI 45.04
  • TEVA 74.33
  • Support Level
  • SMCI $30.54
  • TEVA $14.17
  • Resistance Level
  • SMCI $34.13
  • TEVA $16.86
  • Average True Range (ATR)
  • SMCI 1.97
  • TEVA 0.59
  • MACD
  • SMCI 0.06
  • TEVA 0.44
  • Stochastic Oscillator
  • SMCI 36.84
  • TEVA 95.91

About SMCI Super Micro Computer Inc.

Super Micro Computer Inc provides high-performance server technology services to cloud computing, data centers, Big Data, high-performance computing, and the "Internet of Things" embedded markets. Its solutions include server, storage, blade, and workstations to full racks, networking devices, and server management software. The firm follows a modular architectural approach, which provides flexibility to deliver customized solutions. The Company operates in one operating segment that develops and provides high-performance server solutions based upon an innovative, modular, and open-standard architecture. More than half of the firm's revenue is generated in the United States, with the rest coming from Europe, Asia, and other regions.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: